Patents by Inventor David Rounbehler

David Rounbehler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO)
    Publication number: 20230294060
    Abstract: A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.
    Type: Application
    Filed: November 28, 2022
    Publication date: September 21, 2023
    Applicant: VERO Biotech Inc.
    Inventors: David FINE, David Rounbehler, Gregory Vasquez, Bryan Johnson
  • Method and apparatus for nitric oxide generation
    Patent number: 8371296
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: May 8, 2006
    Date of Patent: February 12, 2013
    Assignee: Geno, LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Controlled generation of nitric oxide
    Patent number: 8066904
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: November 29, 2011
    Assignee: Geno LLC
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Method and Apparatus for Nitric Oxide Generation
    Publication number: 20070089739
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: May 8, 2006
    Publication date: April 26, 2007
    Applicant: GENO LLC
    Inventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
  • CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITRIC OXIDE (NO)
    Publication number: 20060180147
    Abstract: A nitric oxide delivery system, which includes a gas bottle having nitrogen dioxide in air, converts nitrogen dioxide to nitric oxide and employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid. A nitric oxide delivery system may be used to generate therapeutic gas including nitric oxide for use in delivering the therapeutic gas to a mammal.
    Type: Application
    Filed: March 7, 2006
    Publication date: August 17, 2006
    Applicant: CyTerra Corporation
    Inventors: David Rounbehler, David Fine
  • Nitric Oxide Delivery System
    Publication number: 20060172018
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: April 7, 2006
    Publication date: August 3, 2006
    Applicant: GENO LLC
    Inventors: David Fine, Stephen MacDonald, David Rounbehler, David Wheeler, Jonathan Rolfe, George Jarvis
  • Method and apparatus for nitric oxide generation
    Patent number: 7040313
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: May 9, 2006
    Assignee: CyTerra Corporation
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Nitric oxide delivery system
    Patent number: 7025869
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: April 11, 2006
    Assignee: CyTerra Corporation
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
    Publication number: 20060048779
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
    Type: Application
    Filed: August 18, 2005
    Publication date: March 9, 2006
    Inventors: David Rounbehler, David Fine
  • Controlled generation of nitric oxide
    Publication number: 20030064028
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Nitric oxide delivery system
    Publication number: 20030064115
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis
  • Method and apparatus for nitric oxide generation
    Publication number: 20030062043
    Abstract: Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
    Type: Application
    Filed: August 28, 2002
    Publication date: April 3, 2003
    Inventors: David H. Fine, Stephen J. MacDonald, David Rounbehler, David Wheeler, Jonathan L. Rolfe, George Jarvis